ストックスクリーナーアプリを入手
0.0759
4.29%
-0.0034
アフターアワーズ：
.07
-0.0059
-7.77%
前日終値:
$0.0793
開ける：
$0.0732
24時間の取引高:
2.33M
Relative Volume:
0.21
時価総額：
$1.10M
収益：
-
当期純損益:
$-53.12M
株価収益率:
-0.000698
EPS:
-108.8
ネットキャッシュフロー:
$-15.86M
1週間 パフォーマンス:
-29.53%
1か月 パフォーマンス:
-69.94%
6か月 パフォーマンス:
-98.31%
1年 パフォーマンス:
-98.86%
1日の値動き範囲:
$0.067
$0.0759
1週間の範囲:
$0.065
$0.0999
52週間の値動き範囲:
$0.065
$21.40
Onconetix Inc Stock (ONCO) Company Profile
ONCO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
0.0759 | 1.10M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 124.29B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 68.39B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
590.06 | 35.99B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.93B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
264.32 | 28.47B | 3.81B | -644.79M | -669.77M | -6.24 |
Onconetix Inc (ONCO) 最新ニュース
Onconetix Appoints Karina Fedasz as Interim CEO - TipRanks
Onconetix Delays Yearly Report Filing - TipRanks
Pre-market Movers: RGLS, SLNO, OCEA, OSRH... - RTTNews
Onconetix claims validation of prostate cancer test Proclarix in Danish cohort - Yahoo Finance
Onconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohort - GlobeNewswire
Onconetix reveals Proclarix’s clinical performance at EAU congress - Investing.com India
Onconetix Announces Successful Clinical Validation Of Proclarix For Prostate Cancer In Danish Cohort - Nasdaq
Onconetix reveals Proclarix’s clinical performance at EAU congress By Investing.com - Investing.com South Africa
Onconetix Inc. Presents Promising Clinical Data for Proclarix® at 2025 EAU Congress - Nasdaq
Revolutionary Prostate Cancer Test Cuts Unnecessary Biopsies by 22%, Shows 96% Detection Rate - Stock Titan
Onconetix Inc (NASDAQ: ONCO): Blank Check On Growth? - Stocks Register
Onconetix Announces New Clinical Data for its Innovative - GlobeNewswire
Onconetix to Present Proclarix at EAU Congress 2025 - TipRanks
Onconetix, Inc. to Present Proclarix Study Results at 2025 EAU Congress in Madrid - Nasdaq
Groundbreaking 800-Patient Study Shows How Onconetix's Proclarix Test Prevents Unnecessary Prostate Biopsies - StockTitan
ONCO stock plunges to 52-week low, touches $0.12 By Investing.com - Investing.com Australia
ONCO stock plunges to 52-week low, touches $0.12 - Investing.com India
Onconetix taps industry veteran as executive chairman amid CEO resignation - The Business Journals
Onconetix names new executive chairman, appoints board member By Investing.com - Investing.com Australia
Onconetix names new executive chairman, appoints board member - Investing.com India
Onconetix Announces Leadership Changes and New Appointments - TipRanks
Onconetix Says Ralph Schiess Resigns As Interim CEO And Chief Science Officer -February 28, 2025 at 05:35 pm EST - Marketscreener.com
Onconetix secures new financing, appoints auditor, sees executive exit By Investing.com - Investing.com South Africa
Onconetix secures new financing, appoints auditor, sees executive exit - Investing.com
Onconetix Announces Promissory Note Agreement with Keystone - TipRanks
Investing in Onconetix Inc (ONCO) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Onconetix Inc (ONCO) Stock: A Year of Decreases and Increases - The InvestChronicle
Daily Market Movement: Onconetix Inc (ONCO) Sees a 11.91 Increase, Closing at 0.61 - The Dwinnex
Onconetix files to sell 50M shares of common stock for holders - MSN
Stock market today: Allakos dropped by 76.37% whereas Onconetix jumped by 77.10% in early trading - Business Upturn
Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Onconetix faces Nasdaq delisting over share price rule - MSN
Onconetix faces Nasdaq delisting over share price rule By Investing.com - Investing.com Nigeria
Onconetix settles with IQVIA, adjusts accounts payable - MSN
Onconetix settles with IQVIA, adjusts accounts payable By Investing.com - Investing.com Canada
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet - Benzinga
ONCO Stock Plummets to 52-Week Low at $0.37 Amid Market Struggles By Investing.com - Investing.com South Africa
Onconetix files overdue quarterly report, addresses Nasdaq notice By Investing.com - Investing.com South Africa
Onconetix files overdue quarterly report, addresses Nasdaq notice - Investing.com
Onconetix, Inc. Announces Receipt of Notice from Nasdaq - GlobeNewswire
Onconetix Resolves Nasdaq Compliance Issue After Late Q3 Filing - StockTitan
ONCO stock touches 52-week low at $0.58 amid market challenges - Investing.com India
Onconetix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Onconetix Inc. (ONCO) reports earnings - Quartz
Onconetix amends forbearance agreement with Veru Inc. - Investing.com
ONCO Stock Hits 52-Week Low at $0.6 Amid Market Challenges - Investing.com Nigeria
Onconetix Inc (ONCO) 財務データ
収益
当期純利益
現金流量
EPS
1.23%
1.63%
大文字化:
|
ボリューム (24 時間):